Is It Still Worth Buying GSK After a 46% Rally in Shares This Year
GSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
During crashes, passive index funds typically deliver steadier exposure and lower fees, while active funds may outperform briefly but incur higher risks and costs.
24,770 articlesGSK has seen a steep run in its stock, prompting questions about whether the rally still offers upside. This article ...
As Washington rejects a retail CBDC on paper, a private-dollar regime gains power with transfer controls. The questio...
Jim Cramer warns that AppLovin's blistering margins could attract a Google-sized challenger in ad tech. The alert fol...
Howard Hanna NYC appoints Hal Gavzie as executive director of business development, signaling a bold push to expand i...
House Democrats introduced the Death Bets Act to outlaw prediction markets tied to war outcomes and fatalities amid o...
Howard Schultz and his wife plan a move to Florida as Washington considers a roughly 10% annual tax on earnings above...
Oil climbs to the upper $90s per barrel as defense spending expands and aviation MRO demand stays tight. Analysts say...
Nvidia’s CEO Jensen Huang faces a modest cash bonus despite a multitrillion-dollar market cap, highlighting how execu...
Mastercard launches a global Crypto Partner Program that includes Solana, signaling real-world use. Analysts weigh ho...
Two frontier AI firms are tipped for 2026 IPOs, with lofty valuations and aggressive monetization bets, as markets we...
A veteran executive coach shows how Beat the Plan helps Fortune 500 leaders cut decision time, improve quality, and s...
Garmin, Synaptics, and QuantumScape blend device hardware, AI-ready tech, and next-gen batteries in a low-profile tri...